Last reviewed · How we verify

NCT06855199

CAUDAL EPIDURAL BLOCK IN PEDIATRIC SURGERY CASES

Recruiting now Last updated 3 March 2025
What this trial tests

trial in Pediatric Patient in 55 participants. Currently enrolling.

Timeline
10 November 2024
Primary endpoint
10 November 2024
30 June 2025

Quick facts

Lead sponsorCigdem Demirci
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment55
Start date10 November 2024
Primary completion10 November 2024
Estimated completion30 June 2025
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Cigdem Demirci

Who can join

Adults 1 to 6, any sex, with Pediatric Patient. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Caudal epidural anesthesia was reported as the first epidural anesthesia technique in 1933, but its use began to become widespread after the 1960s (1). The procedure is reliable, easy to perform, the incidence of complications is low, and the total complication rate is 1.5/1000; Serious complications occur at a rate of 1/40000. There are many methods to demonstrate the success of caudal epidural block. Some of the common traditional methods are changes in mean arterial pressure and heart rate. These methods are sometimes not objective and take time. In this study, we will examine the block success in pediatric patients who underwent caudal epidural block, which is applied in our hospital, whether the Galvanic skin response measured with a finger probe, other than traditional methods, correlates with the block success, and whether it shows faster block success compared to other traditional methods.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06855199.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing